Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Whitehawk Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 39 | 41 | +2 |
| Shares | 29.4M | 28.8M | −601.7K (−2.0%) |
| Value | $54.6M | $54.3M | −$267.5K (−0.5%) |
New holders (5)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| StemPoint Capital LP | 424,082 | $805.8K | 0.16% |
| Stonepine Capital Management, LLC | 35,253 | $67.0K | 0.05% |
| Acadian Asset Management LLC | 26,206 | $49.0K | 0.00% |
| XTX Topco Ltd | 19,780 | $37.6K | 0.00% |
| Simplex Trading, LLC | 35 | $0 | 0.00% |
Sold out (3)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| EcoR1 Capital, LLC | 1,091,417 | $2.04M |
| Two Sigma Securities, LLC | 11,103 | $20.8K |
| Federated Hermes, Inc. | 358 | $669 |